Artivion Inc. manufactures and distributes medical devices and implantable human tissues, primarily targeting healthcare providers such as hospitals and surgeons. The company's revenue comes from a diverse range of products, including BioGlue (15-20%), cardiac preservation services (10-15%), PhotoFix (10-15%), and various stent grafts and vascular grafts (40-50%). Other offerings include surgical hemostats and prosthetic heart valves, contributing to the remaining revenue. Factors supporting endurance include a growing demand for advanced medical devices and a strong focus on innovation, while potential limitations include regulatory challenges and competition from other medical device manufacturers.
—
Artivion Inc. manufactures and distributes medical devices and implantable human tissues, primarily targeting healthcare providers such as hospitals and surgeons. The company's revenue comes from a diverse range of products, including BioGlue (15-20%), cardiac preservation services (10-15%), PhotoFix (10-15%), and various stent grafts and vascular grafts (40-50%). Other offerings include surgical hemostats and prosthetic heart valves, contributing to the remaining revenue. Factors supporting endurance include a growing demand for advanced medical devices and a strong focus on innovation, while potential limitations include regulatory challenges and competition from other medical device manufacturers.
—
Daily adjusted close
Artivion Inc. manufactures and distributes medical devices and implantable human tissues, primarily targeting healthcare providers such as hospitals and surgeons. The company's revenue comes from a diverse range of products, including BioGlue (15-20%), cardiac preservation services (10-15%), PhotoFix (10-15%), and various stent grafts and vascular grafts (40-50%). Other offerings include surgical hemostats and prosthetic heart valves, contributing to the remaining revenue. Factors supporting endurance include a growing demand for advanced medical devices and a strong focus on innovation, while potential limitations include regulatory challenges and competition from other medical device manufacturers.